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Abstract
Background: The malarial parasite, Plasmodium falciparum (Pf), is responsible for nearly 2 million
deaths worldwide. However, the mechanisms of cellular signaling in the parasite remain largely
unknown. Recent discovery of a few protein kinases and phosphatases point to a thriving reversible
phosphorylation system in the parasite, although their function and regulation need to be
determined.
Results:  We provide biochemical and sequence evidence for a protein serine/threonine
phosphatase type PP5 in Plasmodium falciparum, and named it PfPP5. The 594-amino acid
polypeptide was encoded by a 1785 nucleotide long intronless gene in the parasite. The
recombinant protein, expressed in bacteria, was indistinguishable from native PfPP5. Sequencing
comparison indicated that the extra-long N-terminus of PfPP5 outside the catalytic core contained
four tetratricopeptide repeats (TPRs), compared to three such repeats in other PP5 phosphatases.
The PfPP5 N-terminus was required for stimulation of the phosphatase activity by polyunsaturated
fatty acids. Co-immunoprecipitation demonstrated an interaction between native PfPP5 and Pf heat
shock protein 90 (hsp90). PfPP5 was expressed in all the asexual erythrocytic stages of the parasite,
and was moderately sensitive to okadaic acid.
Conclusions: This is the first example of a TPR-domain protein in the Apicomplexa family of
parasites. Since TPR domains play important roles in protein-protein interaction, especially relevant
to the regulation of PP5 phosphatases, PfPP5 is destined to have a definitive role in parasitic growth
and signaling pathways. This is exemplified by the interaction between PfPP5 and the cognate
chaperone hsp90.
Background
On the basis of sequence homo logy and similarity of
three-dimensional structures, phosphoprotein phos-
phatases (PPases) have been classified into three fami-
lies designated PPP, PPM, and PTP [reviewed in [1–3].
The PPP and PPM families are comprised of phosphoser-
ine- and phosphothreonine-specific enzymes whereas
the PTP family consists of phosphotyrosine-specific and
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dual-specificity enzymes [4]. The major members of the
PPP family are PP1, PP2A, and PP2B (calcineurin) class
of phosphatases. Protein phosphatase 5 (PP5), a newer
member of the PPP family, differs from the other Ser/
Thr phosphatases in that it contains regulatory and
(sub)cellular targeting functions within a single polypep-
tide [5–7]. While its catalytic core exhibits strong simi-
larity to those of the other members of this family, its N-
terminus consists of three tetratricopeptide repeats
(TPRs) that are unique to the PP5 class. TPR domains
consist of a series of antiparallel amphipathic α  helices
that bundle together through hydrophobic interactions
to form a cradle-shaped groove, postulated to be in-
volved in binding a number of proteins of regulatory im-
portance such as heat shock protein 90, a major cellular
chaperone [8–10].
The Apicomplexan family of parasites, exemplified by
Plasmodia, are major disease agents of humans. As the
causative agent of malaria, Plasmodia sp. alone infects
about 300 million people globally and results in an annu-
al death toll of nearly 2 million [11]. Plasmodium falci-
parum (Pf) is the most virulent of all and causes fatal
cerebral malaria. Because of the continual emergence of
drug-resistant parasites throughout the world, a need for
a fundamental knowledge of the signaling pathways of
the parasite has been recognized. In the recent past, this
has led to the identification of a number of Plasmodium
protein phosphatases, some putative [12,13], others ex-
perimentally demonstrated [e.g., [14–16]]. Most of these
phosphatases resembled the classical mammalian PP1,
PP2A, PP2B and PP2C enzymes [12,14,16], and some
were potentially novel Ser/Thr phosphatases [13,15,16].
In this report, we describe the cloning and characteriza-
tion of a novel PP5 phosphatase from Pf (PfPP5) that
contains an unusually long N-terminal extension that
contained four putative TPR motifs and played an im-
portant role in fatty acid-mediated activation of the en-
zyme. The structural and biochemical properties of
PfPP5 described herein are hallmarks of the PP5 class,
and thus establish PfPP5 as a likely player in parasitic
signal transduction, and hence a potential target for anti-
malarial drug design.
Results
Identification of PfPP5 cDNA and gene
To identify new Ser/Thr phosphatases of Pf, we have re-
cently undertaken a PCR-based approach. At first, we
made degenerate deoxyoligonuclotide primers corre-
sponding to the conserved peptide sequences GDXHGQ
and GDXVDRG of PPs [17]. An approximately 120 bp
PCR product, obtained by using these primers with the
Pf 3D7 genomic DNA as template, was cloned in the
pGEM-T vector (Promega) using the T/A cloning strate-
gy. Sequencing of individual clones revealed a variety of
potential PPP sequences in Pf, one of which was an exact
match with a putative open reading frame (ORF) on Pf
chromosome 13 in the sequence database of the Sanger
Center (Accession No. AL049185). Comparison of the
predicted primary structure of the protein clearly re-
vealed its similarity with known members of the PP5
family, including the presence of multiple TPR domains
(Fig. 1 and 2). Specific primers were then made against
this ORF and the 1578 base pair gene was cloned and
confirmed by sequencing. The same set of primers were
then used to amplify the PfPP5 cDNA sequence from a
poly(A)-enriched mRNA population of Pf strain Dd2.
This sequence fully matched the genomic Sanger se-
quence, suggesting the lack of introns in the PfPP5 gene.
Recombinant expression of PfPP5
To express the putative PfPP5 protein, we subcloned it in
the bacterial expression vector pET-15b and introduced
the plasmids into E. coli BL21(DE3). As shown in Fig. 3,
when induced with IPTG, the pET-15b-PfPP5 clone pro-
duced a polypeptide of approximate Mr 70 k (lane 2),
which is in excellent agreement with the calculated MW
of 69,139, considering that pET-15b adds a (His)6 tag
(about 2 kDa) to the N-terminus of the recombinant pro-
tein. The presence of the (His)6 tag could be confirmed
by anti-His antibody in immunoblot (data not shown).
The His-tagged PfPP5 was subsequently purified
through standard nickel-chelation chromatography (Fig.
3, lane 5). Using 32P-labeled histone as substrate under
standard assay conditions (in absence of any activator),
the specific activity of the recombinant PfPP5 was meas-
ured to be 198 ± 25 nmoles of 32P/min/mg enzyme.
The deletion mutant, ∆ TPR-PfPP5, was similarly cloned
by PCR using a primer corresponding to the internal se-
quence, and purified by nickel chelation affinity chroma-
tography. The deletion mutant starts with Met-273, as
described in Fig. 1.
Identification of native parasitic PP5
To identify whether PfPP5 is actually expressed in the
parasite, cell-free extracts of the asynchronous erythro-
cytic stage parasites were subjected to standard chroma-
tographic procedures that had been previously
optimized for human PP5 [18]. Studies of mammalian
PP5 have revealed that the TPR domain might act as an
auto-inhibitory domain of the phosphatase activity, and
that tryptic digestion of PP5 causes loss of the TPRs and
concomitant stimulation of activity [19–21]. As de-
scribed under Materials and Methods, the purification
was in fact monitored by assaying for a trypsin-activated
phosphatase with the assumption that PfPP5 may be-
have like mammalian PP5 in this regard [18,20,21]. As
mentioned, the activity peaks always coincided with aBMC Microbiology 2001, 1:31 http://www.biomedcentral.com/1471-2180/1/31
Figure 1
Comparison of the primary structure of PfPP5 with representative orthologs. The predicted sequences of PP5 from the follow-
ing organisms (abbreviation and accession numbers in parenthesis) were aligned using the CLUSTALW multiple alignment pro-
gram at the European Bioinformatics Institute (EMBL) server, and later refined by visual inspection: Plasmodium falciparum (Pf;
AL049185); Trypanosoma brucei (Tb, AAG40278); S. cerevisiae (Sc, P53043); C. elegans (Ce, CAB60937); Drosophila melanogaster
(Dm, AAF54438); Xenopus laevis (XI, AAB70574); Homo sapiens (Hs, AAD22669). The numbers of amino acid residues are
shown on the right. The four proposed TPR domains of PfPP5, the spacer, and a helix are so indicated. Specific amino acid res-
idues important in autoinhibition and interaction with hsp90 with mammalian PP5 are underlined on the bottom (human)
sequence. Residues that are identical or conservative replacements (T, S; A, M, L, I, V; D, E; R, K; Q, N; F, Y) in at least 4
sequences are highlighted in gray. The TPR-deletion mutant starts at Met-273 (bold).
Pf                        MLHNHDVEEEDDIAQTDEVLMSDEEINNDFHLEIGEYSKNHKCDDPLNNNKTDHCDKERKDICLELLKT   69 
Tb                        ----------------------------------------------MAG-----------------VEE    6 
Sc                        ------------------------------------------MSTPTAA----------------DRAK   11 
Ce                        ----------MAATITDDIVAT--------------------VLESIEE--KSYED---------EKEK   28 
Dm                        -MSSSELEVQKAADCQQEAKVP--------------------ASVEITGSKQPEEDTNARTKAELDFAA   48 
Xl                        ---------------AEEER-----------------------AVEAGG--EPTSN---------KEKT   20 
Hs                        ------------MAMAEGERTE--------------------CAEPPRD--EPPADG--------ALKR   27 
                                    
                PfPP5 TPR1                    Spacer                   PfPP5 TPR2 
 
Pf   CDALKNIGNKYFKENNYIISLRYYTEAIDLIKKSEQCPNNVTDIDNENNTNNLHDFDVEVDDEDKELFKEYYNKSAISKKSDFISIKETD  159 
Tb   ADKLKQLGNAAFSERKWHLAIDMYTKAIELTKT---------------------------------------------------------   39 
Sc   ALERKNEGNVFVKEKHFLKAIEKYTEAIDLDSTQ--------------------------------------------------------   45 
Ce   AGMIKDEANQFFKDQVYDVAADLYSVAIEIHPT---------------------------------------------------------   61 
Dm   AEQYKNQGNEMLKTKEFSKAIDMYTKAIELHPNS--------------------------------------------------------   82 
Xl   AEELKEQANEYFRVKDYDHAVQYYTQAIDLSPDT--------------------------------------------------------   54 
Hs   AEELKTQANDYFKAKDYENAIKFYSQAIELNPSN--------------------------------------------------------   61 
 
                 PfPP5 TPR3                      PfPP5 TPR4                    Helix..... 
 
Pf   LHIYYTNRSFCHIKLENYGTAIEDIDEAIKINPYYAKAYYRKGCSYLLLSDLKRASECFQKVLKLT-KDKNSELKLKQCKKLIFEQQFQK  248 
Tb   -PTLFCNRALAELRAELPGAALADADAALGIEPTFAKAYYHKASAYLSLGKHKQALTNYKKVVDLAPQNTDAQAKVEFCKKEIRRINFEN  128 
Sc   -SIYFSNRAFAHFKVDNFQSALNDCDEAIKLDPKNIKAYHRRALSCMALLEFKKARKDLNVLLKAKPNDPAATKALLTCDRFIREERFRK  134 
Ce   -AVLYGNRAQAYLKKELYGSALEDADNAIAIDPSYVKGFYRRATANMALGRFKKALTDYQAVVKVCPNDKDARAKFDECSKIVRRQKFEA  150 
Dm   -AIYYANRSLAHLRQESFGFALQDGVSAVKADPAYLKGYYRRAAAHMSLGKFKQALCDFEFVAKCRPNDKDAKLKFTECNKIVKMRAFER  171 
Xl   -AIYYGNRSLAYLRTECYGYALADASRAIQLDAKYIKGYYRRAASNMALGKLKAALKDYETVVKVRPHDKDAQMKFQECNKLVRQKAFER  143 
Hs   -AIYYGNRSLAYLRTECYGYALGDATRAIELDKKYIKGYYRRAASNMALGKFRAALRDYETVVKVKPHDKDAKMKYQECNKIVKQKAFER  150 
 
     .......Helix 
 
Pf   AIELE---QKMPYYET---LVLDSLKIEN-MEAPIYDRN---------------NLNLDFLKKVADYISIPNNKLNKKCVCAIVLDVIKL 316 
Tb   AITTP---DEAPLSQT---IKLGSVRADYD--GPRIENE---------------TVTVELVEAMKEHFRL-EKLIDRHDVIFILLEVQKI 194 
Sc   AIGGAENEAKISLCQTLNLSSFDANADLANYEGPKLEFEQLYDDKNAFKGAKIKNMSQEFISKMVNDLFLKGKYLPKKYVAAIISHADTL 224 
Ce   AISTDH--DKKTVAET---LDINAMAIEDSYDGPRLED----------------KITKEFVLQLIKTFKN-QQKLHKKYAFKMLLEFYNY 218 
Dm   AIAVDK--PEKTLSEMY--SDMENITIEDDYKGPQLEDG---------------KVTLKFMKELMEHYKA-QKRLHRKFAYKILCEIDTY 241  
Xl   AIACEQ--HNRSVVDS---LDIEGMTIEDEYTGPQLQDG---------------NVTVDFMLELMQFYKD-QKKLHRKCLYQMLVQVKDI 212 
Hs   AIAGDE--HKRSVVDS---LDIESMTIEDEYSGPKLEDG---------------KVTISFMKELMQWYKD-QKKLHRKCAYQILVQVKEV 219 
 
Pf   LKELPTLVYLN--LEEDETLTICGDVHGQYYDLLNIMKINGYPSEKNSYLFNGDFVDRGSFSVEVIIFLYLAKLTFPNNVYLTRGNHETD 404 
Tb   LKKCPNFVSIN--VPVGEDITVCGDTHGQYYDLLNIFKLNGNPLETNRYLFNGDFVDRGSYSFGNIMTLFAYKVLYPDHFFLSRGNQEGV 282 
Sc   FRQEPSMVELENNSTPDVKISVCGDTHGQFYDVLNLFRKFGKVGPKHTYLFNGDFVDRGSWSCEVALLFYCLKILHPNNFFLNRGNHESD 314 
Ce   VKSLPTMVEIT--VPTGKKFTICGDVHGQFYDLCNIFEINGYPSETNPYLFNGDFVDRGSFSVETIFTMIGFKLLYPNHFFMSRGNHESD 306 
Dm   MRAQPSLVDIT--VPDEEKFTICGDIHGQFYDLMNIFEINGLPSEKNPYLFNGDFVDRGSFSVECIFTLFGFKLLYPNHFFLARGNHESI 329 
Xl   LSKLPSLVEVS--LEKSQQVTVCGDTHGQFYDLMNIFHLNGLPSENNPYIFNGDFVDRGSFSVEVIVTLFGFKLLYPAHFHLLRGNHETD 300 
Hs   LSKLSTLVETT--LKETEKITVCGDTHGQFYDLLNIFELNGLPSETNPYIFNGDFVDRGSFSVEVILTLFGFKLLYPDHFHLLRGNHETD 307 
 
Pf   NMNKIYGFLGELQEKYDEKMHVLFSDSFKFLPLAYVLNKNIFICHGGIPSKTDTTLEDIEKIDRNKEPLDEGVMTDLLWS---------- 484 
Tb   SMNRMYGFEGEVTQKYNSEMFRLFTEVFNSPPIGHINNNEVFVLHGGLYSSDKVTLDDLQQPNRFRDIPESGLICESLWS---------- 362 
Sc   NMNKIYGFEDECKYKYSQRIFNMFAQSFESLPLATLINNDYLVMHGGLPSDPSATLSDFKNIDRFAQPPRDGAFMELLWA---------- 394 
Ce   VMNKMYGFEGEVKAKYTQQMCDMFTETFCWLPLCHLINEKIFVCHGGLFKEDGVTLEDIRKTDRNRQPPDEGIMCDLLWEKNWKNLKILY 396 
Dm   NMNQMYGFTGEVTAKYTSAMADIFTQVFNWLPLCHCINQKILVMHGGLFSTEDVTLDHIRRIERNCQPPEEGLMCELLWS---------- 409 
Xl   TMNQMYGFEGEVKAKYSAQMFQLFSEVFQWLPLAMCVNQRVLIMHGGLFSEDGVTLDQIRNIERNRQPPDSGPMCDLLWS---------- 380 
Hs   NMNQIYGFEGEVKAKYTAQMYELFSEVFEWLPLAQCINGKVLIMHGGLFSEDGVTLDDIRKIERNRQPPDSGPMCDLLWS---------- 387 
 
Pf   --------------------DPNEEKGFKPSKRGIGFS-FGTDITENFLKINNLSLIIRSHEVRDEGYSLEQNGQLYTVFSAPNYCDIMK 553 
Tb   --------------------DPQPMPGRAPSKRGVSCLSFGPDVTETFLNNNNLKLLVRSHEVKDEGYEIEHGGKCITVFSAPNYCDQMG 432 
Sc   --------------------DPQEANGMGPSQRGLGHA-FGPDITDRFLRNNKLRKIFRSHELRMGGVQFEQKGKLMTVFSAPNYCDSQG 463 
Ce   PDGKINKNSNCQPKTCKNASDPQPINGRSPSKRGVGCQ-FGPDVTSKWCETNGIEYVVRSHEVKPEGYEMHHNGQCFTVFSAPNYCDQMN 485 
Dm   --------------------DPQQWMGLGQSKRGVGIQ-FGPDVTEKFCKDNNLDYIIRSHEVKDMGYEVAHNGKCITVFSAPNYCDTMG 478 
Xl   --------------------DPQPQDGRSTSKRGVSCQ-FGPDVTHQFLEENGLDYIIRSHEVKPEGYEVSHNGLCVTVFSAPNYCDQMG 449 
Hs   --------------------DPQPQNGRSISKRGVSCQ-FGPDVTKAFLEENNLDYIIRSHEVKAEGYEVAHGGRCVTVFSAPNYCDQMG 456 
 
Pf    NKGAFLKFK----------GNSIKPECVTFTEVEHPNVPSLKYAHNLYQNI-- 594 
Tb    NKGAFIRFT----------GGDMKPRFTTFTHVPHPGKRPMHYATGFGLF--- 472 
Sc    NLGGVIHVVPGHGILQAGRNDDQNLIIETFEAVEHPDIKPMAYSNGGFGL--- 513 
Ce    NKGAFITIT----------GDNLTPRFTPFDAVPHPKLPPMAYANSLFGFN-- 526 
Dm    NMGAFITIT----------GNNLKPNYKSFEAVPHPDVKPMAYANSLMNWLA- 520 
Xl    NKGAYIHLS----------GSDLKPKFHQFEAVPHPNVKPMMYANSLLQMGMM 492 
Hs    NKASYIHLQ----------GSDLRPQFHQFTAVPHPNVKPMAYANTLLQLGMM 499 BMC Microbiology 2001, 1:31 http://www.biomedcentral.com/1471-2180/1/31
~69 kDa band in parallel Western analyses of the chro-
matographic fractions. In SDS-PAGE, the partially puri-
fied fraction contained a major polypeptide of the
expected size (69 kDa) (Fig. 4, lane 2). In Western blot,
the rabbit antibody raised against the purified recom-
binant protein also specifically reacted with the native
Figure 2
Comparison of representative PP5 TPR domains. The TPR domains of the PfPP5 are aligned with those of the other PP5 phos-
phatases (same as in Fig. 1) to illustrate their conserved sequence features. The structurally important hydrophobic ('b') and
hydrophilic residues ('l'), and the two helices (A, B) are marked [8,9]. Residues numbered 4, 8, 11, 20, 24, and 27 are located on
the same face of their respective helices, and may be involved in the recruitment of TPR-interacting proteins [8,9].
 
       Helix A             Helix B              
 
            b--bl--b--bbl---b-lbb--bllbb-b---- 
                                                  4            8       11                          20         24      27  
Pf1     70  CDALKNIGNKYFKENNYIISLRYYTEAIDLIKKS 103 
Pf2:   126  DVEVDDEDKELFKEYYNKSAISKKSDFISIKETD 159 
Tb1:     7  ADKLKQLGNAAFSERKWHLAIDMYTKAIELTKT-  39 
Sc1:    12  ALERKNEGNVFVKEKHFLKAIEKYTEAIDLDSTQ  45 
Ce1:    29  AGMIKDEANQFFKDQVYDVAADLYSVAIEIHPT-  62 
Dm1:    47  AEQYKNQGNEMLKTKEFSKAIDMYTKAIELHPNS  80 
Xl1:    21  AEELKEQANEYFRVKDYDHAVQYYTQAIDLSPDT  54 
Hs1:    28  AEELKTQANDYFKAKDYENAIKFYSQAIELNPSN  61 
 
 
                                                   4           8       11                          20         24      27 
Pf3:   161  HIYYTNRSFCHIKLENYGTAIEDIDEAIKINPYY 194 
Tb2:    40  PTLFCNRALAELRAELPGAALADADAALGIEPTF  73 
Sc2:    46  SIYFSNRAFAHFKVDNFQSALNDCDEAIKLDPKN  79 
Ce2:    63  AVLYGNRAQAYLKKELYGSALEDADNAIAIDPSY  96 
Dm2:    81  AIYYANRSLAHLRQESFGFALQDGVSAVKADPAY 114 
Xl2:    55  AIYYGNRSLAYLRTECYGYALADASRAIQLDAKY  88 
Hs2:    62  AIYYGNRSLAYLRTECYGYALGDATRAIELDKKY  95 
 
 
                                                  4            8       11                          20         24      27  
Pf4:   195  AKAYYRKGCSYLLLSDLKRASECFQKVLKLT-KD 227 
Tb3:    75  AKAYYHKASAYLSLGKHKQALTNYKKVVDLAPQN 108   
Sc3:    80  IKAYHRRALSCMALLEFKKARKDLNVLLKAKPND 113 
Ce3:    97  VKGFYRRATANMALGRFKKALTDYQAVVKVCPND 130 
Dm3:   115  LKGYYRRAAAHMSLGKFKQALCDFEFVAKCRPND 148 
Xl3:    89  IKGYYRRAASNMALGKLKAALKDYETVVKVRPHD 122 
Hs3:    96  IKGYYRRAASNMALGKFRAALRDYETVVKVKPHD 129 
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polypeptide (Fig. 4, lanes 5, 6). A similar fraction pre-
pared from uninfected erythrocytes contained very little
protein (Fig 4, lane 3), and did not react with the anti-
body (lane 7). A pre-immune serum served as a negative
control (Fig 4, lane 9). As expected, the native Pf protein
was about 2 kDa smaller than the His-tagged recom-
binant (compare the native band in lanes 2, 5, and 6 with
the recombinant in lanes 4 and 8). Using phosphohis-
tone as substrate, the native Pf enzyme exhibited a spe-
cific activity of 210 ± 20 nmoles of 32P per minute per mg
enzyme, which is comparable to that of the recombinant
enzyme. Together, these results demonstrated the equiv-
alence of the native and recombinant proteins, and in
turn, confirmed the authenticity of the cDNA sequence.
Primary structure of PfPP5
When the predicted primary structure of PfPP5 was
aligned with known PP5 sequences (Fig. 1), the following
features were obvious. First, PfPP5 contained the cata-
lytic core found in all Ser/Thr phosphatases of the PPP
family, including the signature motifs such as GDXHGQ,
GDFVDRG, RGNHE, HGLL, and SAPNYCD, to name a
few [22,23]. Site-directed mutagenesis and structural
studies in PP 1 and PPλ  have previously established the
roles of specific amino acid residues in these domains in
the various aspects of catalysis, such as metal ion bind-
ing, phosphate recognition, and co-ordination of water
molecules [24–26].
While the catalytic core is generally necessary and suffi-
cient for the phosphohydrolase activity of PPP enzymes,
the residues outside the core play critical roles in binding
accessory proteins or small molecules that modulate the
catalytic activity [25–29]. Specifically in the PP5 class,
the N-terminus has been shown to contain three TPR
motifs [5–8], the three-dimensional structure of which is
now also available [8]. Interestingly, the N-terminal se-
quence of PfPP5 was the longest of all, and seemed to
contain four TPR motifs instead of three (Fig. 2). Thus, in
comparing the full sequences of the PP5s, only three of
the four PfPP5 TPRs were aligned with the others, and
the second TPR of PfPP5 was left out. A detailed se-
quence analysis of all the PfPP5 TPRs is offered below.
The TPR motif is a degenerate, 34-amino acid repeat that
is often found in tandem arrays, sometimes separated by
Figure 3
Bacterial expression of recombinant PfPP5. Soluble S100
extract (approximately 30 µg protein) of IPTG-induced
(lanes 2, 4) or uninduced (lanes 1, 3) E. coli BL21(DE3)-RIG
containing pET-15b-PfPP5 (lanes 1, 2) or pET-15b-∆ TPR-
PfPP5 (lanes 3, 4) were analyzed by SDS-PAGE followed by
staining of the gel with Coomassie Brilliant Blue R250 [12].
The respective purified proteins were analyzed in lanes 5, 6.
Lane 7 represents about 5 µg of purified His-tagged PfPP5
digested with 50 ng of trypsin for 30 min at 30°. Protein
markers (lane M) are indicated by their Mr in thousands.
97
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Figure 4
Analysis of native parasitic PP5. The following protein frac-
tions from Pf were analyzed by SDS-PAGE followed by stain-
ing (lanes 1–4) or Western blot using a non-immune
antibody (lane 9) or anti-PP5 antibody (lanes 5–8; 10–13): (1)
S100 extract of Pf cells; (2) partially purified native PfPP5 pro-
tein; (3) corresponding protein fraction from uninfected
RBC; (4) purified recombinant (His)6PfPP5; (5–8) same frac-
tions as lanes 1–4, respectively; (9) same fraction as in lane 1;
(10–13) about 30 µg total protein from asynchronous, late
trophozoite, late schizont / segmented, and ring stage Pf,
respectively. The Mr of protein markers are shown on left in
units of thousands.
1234 5 6 78 9 1 0 1 1 1 2 1 3
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spacer sequences [9]. We propose such a 22-residue
spacer between the first two TPRs of PfPP5 (Fig. 1). Al-
though no single amino acid is absolutely invariant in all
TPRs, they do contain a largely conserved pattern of ami-
no acid similarity in terms of size, hydrophobicity, and
spacing [8,9]. Eight amino acid residues are critically
placed on the same face of their respective helices: 4, 8,
and 11 on the first helix, and 20, 24, and 27 on the second
[8,9]. As shown in Fig. 2, residues that are identical or
have similar hydrophobicity are found in all four pro-
posed TPRs of PfPP5 in the correct relative spacing.
Moreover, secondary structure prediction suggested that
each PfPP5 TPR also has the potential to form the two
conserved helices (A and B), as marked in Fig. 2. Thus, all
the TPRs of PfPP5 may satisfy the structural require-
ments of a TPR motif.
An approximately 34-residue stretch following the last
TPR of PP5 (Fig. 1) shows weak similarity to a TPR motif.
However, alpha-helix prediction and structure determi-
nation have shown that it is a single long helix that ex-
tends out of the TPR domain [8]. Thus, this region may
not represent a typical TPR and therefore, is simply
marked as "helix" in Fig. 1.
Auto-inhibitory role of PfPP5 TPR: activation by polyun-
saturated fatty acids
The biochemical properties further confirmed the PP5-
like nature of the Pf enzyme. First of all, members of the
PP5 class are distinguished by their profound stimula-
tion by polyunsaturated fatty acids [19–21,30]. As shown
in Fig. 5, the phosphatase activity of PfPP5 increased
with increasing concentrations of arachidonic acid and
oleic acid. At its highest, the fatty-acid stimulated activity
was about 3 times the basal activity and was exhibited at
approximately 70 and 80 µM of arachinodic and oleic ac-
ids, respectively. In contrast, stearic acid, a saturated fat-
ty acid, did not appreciably stimulate PfPP5 activity.
To test the role of TPR region in this activation, a TPR de-
letion mutant of PP5 (∆ TPR-PfPP5) starting at the Met-
273 was expressed with an N-terminal (His)6 tag. The re-
combinant protein was expressed from pET-15b clone
and purified by Ni-chelation chromatography (Fig. 3,
lane 6). In SDS-PAGE analysis, ∆ TPR-PfPP5 exhibited a
Mr of approximately 40 k as expected (predicted size of
37,098 for the PP5 part plus about 2,000 for the His6
tag). Interestingly, the specific activity of the ∆ TPR-
PfPP5 enzyme was about 3-times that of the full-length
PfPP5 without arachidonic acid (580 ± 35 nmoles of 32P
per minute per mg enzyme; Fig. 5). Moreover, unlike the
full-length enzyme, ∆ TPR-PfPP5 was not activated by
arachidonic acid, suggesting that the TPR region is re-
quired for the activation.
These results are reminiscent of similar studies done in
other PP5 enzymes in which mutational inactivation of
the TPR domain resulted in an elevated basal activity and
concomitant reduced response to unsaturated fatty acids
[19]. Such studies led to the proposal that TPR domains
regulate the PP5 catalytic region in a negative manner
and that the interaction of arachidonic acid with TPR re-
lieves this auto-inhibition. This was further supported by
the demonstration that trypsin cleaved PP5 in the
"hinge" sequence connecting the TPR region and catalyt-
ic domain, and that such cleavage produced a highly ac-
tive enzyme which was refractory to further activation by
fatty acids [18,20,21]. To test whether this is also true of
PfPP5, we digested recombinant PfPP5 with trypsin,
which resulted in the production of a trypsin-resistant
fragment that was very similar in size to ∆ TPR-PfPP5
(Fig. 3, lane 7). When assayed for phosphatase activity in
vitro, the trypsin-digested PfPP5 indeed behaved like
∆ TPR-PfPP5 in that it was about 3-fold more active than
the full-length enzyme and was not activated by arachi-
donic acid any further (Fig. 5). Together these results
Figure 5
TPR-dependent activation of PfPP5 by unsaturated fatty
acids. Phosphatase assays were performed using 32P-phos-
phohistone substrate as described under Materials and Meth-
ods. The activities were expressed as the ratio of that
obtained in the absence of any fatty acid, taken as 1. The fol-
lowing PfPP5 preparations were tested against the indicated
fatty acids: recombinant ∆ TPR-PP5 (open triangle); trypsin-
treated recombinant PfPP5 (corresponding to lane 7 in Fig. 3;
filled triangle); and recombinant PfPP5 (all the others).
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suggest a role of PfPP5 TPR in auto-inhibition and in fat-
ty acid-mediated activation.
Okadaic acid sensitivity of PfPP5
The differential sensitivity of the members of the PPP
family to biological toxins has been exploited as a diag-
nostic tool in studying these phosphatases. The marine
toxin okadaic acid (OA), in particular, inhibits the PP2A
class of phosphatases at sub-nanomolar concentrations
(IC50 ~ 0.05 nM) and the PP1 class in the low nanomolar
range (IC50 ~ 5–45 nM). The SAPNYC motif of PPP en-
zymes is essential for OA-binding, and is found in all OA-
sensitive phosphatases including PP1, PP2A, and PP5
[[25,27,28], and references therein]. This motif is also
present in PfPP5 (Fig. 1). Phosphatases lacking this motif
include the PP2B and PP2C classes, which are thus high-
ly resistant to OA. PP2A contains an additional Cys resi-
due two amino acids downstream (underlined in
SAPNYCYRCG), believed to be important for the pro-
found sensitivity of this class to OA [28], and this Cys is
absent in PfPP5 and other PP5 enzymes (Fig. 1). As
shown in Fig. 6, OA inhibited PfPP5 in a dose-dependent
manner, with an IC50 of 5.1 ± 0.2 nM. This moderate OA-
sensitivity further establishes the identity of PfPP5, since
other PP5 enzymes also exhibit an IC50 value for OA in
the 4–6 nM range [18]. The ∆ TPR mutant exhibited an
essentially identical IC50 (not shown), supporting the
notion that the TPR domains do not play a direct role in
the interaction with OA.
PfPP5 binds Pf heat shock protein 90 (hsp90)
Hsp90 is a highly conserved molecular chaperone neces-
sary for viability and for proper folding, processing, and
function of proteins involved in several signal transduc-
tion pathways [31,32]. Interestingly, mammalian hsp90
has been shown to specifically interact with PP5, and this
interaction may have important consequences in PP5
structure and function [33,34]. An hsp90 ortholog has
been described in Pf [35], but its function is currently un-
known. It was, therefore, logical for us to ask whether an
interaction between PP5 and hsp90 also occurs in Pf. To
initiate these studies, we performed a co-immunoprecip-
itation analysis of Pf extracts in which complexes con-
taining PP5 were first precipitated with anti-PP5
antibody and the precipitate then probed with anti-
hsp90 antibody in Western blot. Results (Fig. 7) show
that Pfhsp90 is indeed found in complex with PfPP5,
suggesting a potential role of this interaction in the mu-
Figure 6
Okadaic acid sensitivity of PfPP5. Phosphatase assay using
recombinant PfPP5 (open circles) and the control OA-resist-
ant recombinant PfPPJ (closed circles) were carried out at
various concentrations of OA using 32P-phosphohistone sub-
strate as described under Materials and Methods. Values of a
control reaction lacking OA were taken as 100.
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Figure 7
Complex formation between PfPP5 and Pfhsp90. The follow-
ing abbreviations have been used for the antibodies (labeled
on top): C = non-immune serum; PP = anti-PP5; hs = anti-
hsp90. The protein bands (Western blot) are indicated by
hsp90 or PP5 (on the left), and the sizes of the protein stand-
ards are indicated (on the right) by their Mr values in thou-
sands. Lane numbers are indicated on the bottom. About 0.5
mg of Pf cell pellet was lysed and subjected to immunoprecip-
itation (IP) with either a rabbit antibody against PP5 (lane 5)
or a control non-immune serum (lanes 3) as described under
Materials and Methods. The precipitate was analyzed in SDS-
PAGE followed by Western blot using anti-PP5 (lane 2), anti-
hsp90 (lanes 3–5), or non-immune serum. Total Pf cell
extract (40 µg) was also directly subjected to SDS-PAGE and
Western blot without immunoprecipitation (lanes 1, 2, 4).
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tual regulation of these two important proteins. The
"control" non-immune serum did not react with either
protein (lane 1) and did not precipitate hsp90 (lane 3).
Discussion
We provide biochemical and molecular evidence for a
PP5 protein Ser/Thr phosphatase of P. falciparum that
has the catalytic core of the PPP superfamily and four
tetratricopeptide (34-residue) repeat (TPR) domains
(Fig. 1, 2). We have therefore, tentatively named this en-
zyme PfPP5. To our knowledge, PfPP5 is the only TPR-
containing Plasmodium protein reported at this time.
These domains, and the associated properties such as ac-
tivation by unsaturated fatty acids are by far the most
noteworthy features of PfPP5.
Recently, a PP5 phosphatase was identified in Trypano-
soma[30] that contained the prototype PP5 primary
structure, including three TPR domains at the N-termi-
nus. While mammalian PP5 is activated 10–40 fold by
arachidonic acid, the Trypanosoma PP5, like its Plasmo-
dium counterpart (Fig. 5), was also activated only mod-
estly, about 3-fold. Although the reason behind the lower
activation potential is unknown, at least in PfPP5 it cor-
relates with a similar fold activation following loss of the
TPR domains through either mutagenesis or proteolytic
cleavage (Fig. 3, 5). Thus, it appears that the TPR do-
mains of the primitive parasitic PP5 may be less auto-in-
hibitory that those of their higher eukaryotic
counterparts. Recent mutational analysis of recom-
binant PP5 has identified sequences important in autoin-
hibition [19]. Mutation of Glu-76 (underlined in the
human PP5 in Fig. 1) whose side chain projects away
from the TPR groove, resulted in a 10-fold elevation of
basal activity, and this Glu is conserved in both Pf and
Trypanosoma PP5 (Fig. 1). A role of the C-terminal end
in autoinhibition was conjectured based on the finding
that mutation of Gln-495 (underlined in Fig. 1) elevated
basal activity by 10-fold [19]. This residue is also found in
Pf (Gln-592) although it is not conserved in a number of
other PP5 sequences (Fig. 1). Clearly, detailed mutation-
al analysis of these domains should shed light on the
mechanism of PfPP5 autoinhibition and the role of poly-
unsaturated fatty acids in preventing it.
The TPR motif was originally identified as a protein in-
teraction module in the cell division cycle (CDC) proteins
in yeast [36,37] but has since been shown to occur in pro-
teins with diverse functions in a variety of species [9].
The number of the TPR domains, the spacing between
them, and their placement in the primary structure of the
protein appear variable, and the relative contribution of
the individual TPRs in a given protein has not been stud-
ied. At least four major kinds of macromolecular com-
plexes have been identified that involve TPR domains.
These include complexes involved in anaphase promo-
tion, transcription repression, protein import, and mo-
lecular chaperoning [9,10]. Yeast two-hybrid analysis
and in vitro interaction studies have shown that the TPR
domain of PP5 interacts with the TPR domains of CDC16
and CDC27, which may be important in recruiting PP5 to
the anaphase promoting complex (APC) and to the mi-
totic spindles during cell division (38). Interaction of
PP5 with heat shock protein 90, a chaperone, has re-
ceived special attention because of its potential to regu-
late a variety of pathways. For example, PP5 is a major
component of mature glucocorticoid receptor complexes
of higher eukaryotes and appears to regulate glucocorti-
coid receptor function in vivo [[34] and references there-
in]. Such observations suggest that PP5 may act as a co-
chaperone for hsp90 and raise the possibility that pro-
tein dephosphorylation may play an important regulato-
ry role in protein folding [33,34]. Interestingly, recent
studies have identified a few residues of mammalian PP5
critically important for its interaction with hsp90 [34].
As marked on the human PP5 TPR (underlined in Fig. 1)
the corresponding residues are: Lys-32, Lys-97, and Arg-
101. It is notable that the corresponding residues are also
conserved in PfPP5 TPR. The availability of full-length
and TPR-deleted recombinant PfPP5 clones will now al-
low us to further investigate the exact nature of the
PfPP5-Pfhsp90 complexes, and map the interacting
PfPP5 residues through site-directed mutagenesis.
Clearly, the discovery of PfPP5 and its interaction with
homologous hsp90 will open up new directions in para-
sitic protein/ gene regulation and signaling, and may
lead to specific drug targets.
Conclusions
PfPP5 represents the first TPR-containing protein dis-
covered in the Apicomplexan parasites. In view of the es-
sential role of TPR domains in protein-protein
interaction, further studies of PfPP5 and its TPR domain
will shed new light on phosphatase regulation and the
role of PP5 in these clinically important parasites. As
with mammalian PP5, PfPP5 may also play an important
role in cell division through its interaction with parasitic
CDC proteins. Interaction between the Plasmodium PP5
and heat shock protein 90 may reflect a mutual relation-
ship between protein phosphorylation and protein fold-
ing in this parasite. The role of TPR in this interaction
can be addressed through structure-function analysis of
the recombinant proteins.
Materials and methods
PCR and other procedures
The following oligodeoxynucleotide primers were de-
signed against the putative PfPP5 sequence found on
chromosome 13 (AL049185; Plasmodium falciparum
chr13_002073):                        ATGTTACACAACCATGAT-BMC Microbiology 2001, 1:31 http://www.biomedcentral.com/1471-2180/1/31
GTAGAAGAAG;TAAATGTTTTGATACAAATTAT-
GAGC.  These primers were used to amplify the PfPP5
gene or the cDNA using the Pf3D7 genomic DNA or Dd2
total RNA as template with PCR and RT-PCR, respec-
tively. The RT reaction was performed using AMV re-
verse transcriptase, and all PCRs were performed with a
15:1 mixture of Taq:Pfu polymerase. The products were
cloned into pGEM-T and confirmed by sequencing. The
genomic and cDNA sequences were identical. This se-
quence was then subcloned into the XhoI and BamHI
sites of the pET-15b vector by designing similar primers
but containing the respective restriction sites. The TPR
deletion mutant, starting at Glu-274 (bold in Fig. 1), was
also amplified in a similar manner using specific prim-
ers, and then cloned. Introduction of the plasmids into E.
coli BL21(DE3) cells containing the compatible RIG
plasmid [39], induction of the proteins with IPTG, and
purification through Ni-chelation chromatography were
performed using the His-Bind kit reagents and proce-
dure (Novagen).
Antibodies against PP5 and hsp90 were raised in rabbit
and mouse, respectively, using standard procedures
[40]. Fatty acids were purchased from Sigma (St. Louis,
MO). SDS-PAGE and Western blot using chemilumines-
cence-based detection were performed essentially as de-
scribed [15]. Immunoprecipitation of PfPP5 complexes
followed by immunoblot analysis of the precipitate were
carried out essentially as described [34].
Growth of Plasmodium and purification of PfPP5
P. falciparum (3D7 or Dd2) was grown in human A-pos-
itive erythrocytes and infected cells were harvested at
about 15% parasitemia and lysed by the saponin method
essentially as described [14,15]. PfPP5 was partially puri-
fied using published procedures [18]. In brief, the para-
sites were resuspended in buffer A (50 mM Tris-Cl, pH
7.5, 10% glycerol, 1 mM DTT) plus 20 mM NaCl, 1% Tri-
ton X-100, leupeptin (1 µg/ml), and aprotinin (1 µg/ml)
at an approximate protein concentration of 10 mg per ml.
The suspension was sonicated and the lysate centrifuged
at 100,000 ×  g for 30 min. The supernatant, called "total
extract", was subjected to 45%–60% ammonium sulfate
fractionation. The pellet was resuspended in 10 ml of
buffer B (20 mM HEPES, pH 8.5, 1 mM EDTA, 1 mM
DTT), desalted on a Sephadex G-25 column equilibrated
with buffer B, then subjected to sequential chromatogra-
phy on a 5 ml HiTrap heparin column (Pharmacia) and
then a 5 ml HiTrap Q column (Pharmacia). PP5 activity
was followed during the purification by assaying trypsin-
stimulated pNPPase activity. The fractions were further
confirmed by Western blot using anti-PfPP5 antibody.
Parasite culture was synchronized essentially as de-
scribed earlier [15].
Phosphatase assay
Phosphatase activity against pNPP or phosphohistone
substrates was determined essentially as described pre-
viously. Standard assays were performed in buffer A con-
taining 1 mM EDTA, and additional activators or
inhibitors were added only where mentioned. Reactions
were incubated at 37°C. 32P-labeled phosphohistone was
made as described [14,15,18]. When using phosphohis-
tone as substrate, reactions were carried out in 80 µl fol-
lowed by quantification of the liberated 32Pi by
phosphomolybdate extraction assay [14,15,18]. Reac-
tions were followed with time, and results were corrected
by subtraction of the corresponding values from an en-
zyme-free reaction. When p-nitrophenylphosphate was
used as substrate (at 10 mM), the reaction was scaled up
to 200 µl, and the liberated p-nitrophenol was quantitat-
ed by measurement of absorbance at 415 nm [14,23].
Phosphatase reactions were routinely initiated with the
addition of substrate. Dephosphorylation was kept to
less than 10 % of the total phosphorylated substrate, and
the reaction was linear with respect to enzyme concen-
tration and time. When using potential activators (e.g.,
fatty acids) or inhibitors (e.g., okadaic acid), they were
added to the enzyme mixture 10 minutes prior to initiat-
ing the reaction with the addition of substrate [14].
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